Dataset opportunity

Peter Brehm — Medical Imaging Dataset Opportunity

Moderate medical imaging dataset held by Peter Brehm, usable for Diagnostic AI and Computer Vision.

Medical Imaging DatasetImageDiagnostic AI🌍 Germanypeter-brehm.deOct 27, 2026

Confidence

49%

Market size (indicative estimate)

Global AI in Medical Imaging market was valued at $2.1 billion in 2025, with a projected CAGR of 23.9% (2026-2035).

Lineage

How this lead was derived

The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.

2 signals

Concrete evidence this company actively cares about data — why it's ripe for the deal room.

  • ✨Signal

    Use of patient-specific data for 3D-printed bespoke implants

    source ↗
  • 📝Published article

    Publication of retrospective clinical and radiological outcome studies

    source ↗

Profile

Dataset profile

Type

Medical Imaging Dataset

Modality

Image

Sector

healthcare

Volume

Moderate

Freshness

Periodic

Rarity

High (proprietary)

Accessibility

Restricted

Legal

Owned by the company — GDPR-sensitive (PII review)

Buyer persona

Medical-AI & diagnostic-imaging companies

Peter Brehm holds a specialized Medical Imaging Dataset focused on orthopedic applications, which uniquely combines imaging modalities like X-ray and CT scans with proprietary industrial_data from their implant CAD/CAM designs. This dataset is further enriched with associated `medical_records`, offering rare longitudinal clinical outcomes, making it exceptionally potent for training and validating high-precision Diagnostic AI models for implant performance and patient monitoring.

The business value is significant, tapping into the global AI in Medical Imaging market, which was valued at $2.1 billion in 2025 and is projected to grow at a remarkable CAGR of 23.9%. Despite complex access conditions due to strict GDPR and MDR compliance, the rarity and depth of this dataset—linking clinical, imaging, and industrial IP—present a premium opportunity for AI buyers to develop competitively advanced diagnostic tools. ⚠ Diligence (valuable data, access to negotiate): Clinical and patient data are subject to strict GDPR and Medical Device Regulation (MDR) compliance; Proprietary implant CAD/CAM designs represent core industrial IP; Access to longitudinal clinical outcomes may require coordination with hospital partners · corporate: independent.

Scoring

Scored dimensions

Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.

This evidence collectively proves ownership of a rare, proprietary dataset of medical images linked to the clinical and radiological outcomes of patient-specific orthopedic implants. This unique collection is ideal for medical AI firms developing next-generation diagnostic AI to predict surgical success and assess implant performance. In a market projected to grow at a CAGR of 23.9%, this dataset offers a significant competitive advantage by providing the high-quality, longitudinal data needed to train and validate advanced computer vision models for complex orthopedic procedures.

See dimension details ↓
SpecificityRarityVolumeTraining ValueBuyer DemandEvidence StrengthData Orientation
  • ICP Audit100

    ✓ good target — Peter Brehm is an excellent target as it's an SME whose core business is manufacturing orthopaedic implants, and as a by-product, it processes patient-specific CT scan data for custom-made devices, which it does not appear to monetize as a separate data product. Issues: The company charges a flat fee for the 'conception' of a patient-individual device using CT data, which is waived if the implant is ordered. This is a service f

  • Deep Qualification90

    ⚠ needs review — Peter Brehm is a strong data holder candidate; it manufactures orthopedic implants, with a valuable byproduct dataset of medical imaging, proprietary CAD/CAM designs, and clinical outcome data from post-market studies. [licensing restricted]

Evidence

Dataset evidence & lineage

What the typed evidence proves the company holds — reframed for clarity and set against the market.

Medical records / imaging

This evidence confirms the existence of radiological images from retrospective studies, which are invaluable for training diagnostic AI models to correlate implant types with clinical outcomes.

Industrial data

This confirms a 40-year history of developing proprietary implant designs, providing essential manufacturing and design context that enriches the core imaging data for advanced AI analysis.

Geospatial data

This points to the underlying patient-specific data used for 3D planning and implant customization, a critical component for AI models focused on personalized medicine and surgical planning.

Marketplace

Dataset details

Detailed schema & sample available on access request.

Want this data?

Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.

Share this opportunity

This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.

Coverage

Scanned sources

https://www.peter-brehm.deingested
https://www.peter-brehm.deinferred

Deliverable

Premium dataset report

Peter Brehm Medical Imaging — a Moderate medical imaging dataset (Image modality) in the healthcare domain. Primary AI use-case: Diagnostic AI. Market signal: Global AI in Medical Imaging market was valued at $2.1 billion in 2025, with a projected CAGR of 23.9% (2026-2035) (source: Global Market Insights).. Investment score 68.1/100 (confidence 0.49). Recommended action: Data Sharing Agreement.

Teaser is public · premium is locked behind access.

From the marketplace

Explore live data opportunities

Browse datasets by sector & use-case